Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.60 |
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
| ▸ | GNPAT | O15228 | 1/20 | 0.51 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728032 | 0.99 | MME (0.61) | MMEBACE1GNPATENPEPGAA | |
| SCHEMBL29834943 | 0.96 | MME (0.58) | MMEBACE1LTA4HNAALAD2SLC15A1 | |
| SCHEMBL8630193 | 0.96 | MME (0.58) | MMEBACE1LTA4HNAALAD2SLC15A1 | |
| SCHEMBL29430082 | 0.95 | MME (0.60) | MMEGNPATENPEPLTA4HNAALAD2 | |
| SCHEMBL31206426 | 0.94 | MME (0.58) | MMEGNPATNAALAD2 | |
| SCHEMBL29669678 | 0.93 | MME (0.61) | MMEGNPATENPEPLTA4HGAA | |
| SCHEMBL30638819 | 0.92 | MME (0.61) | MMEBACE1GNPATENPEPGAA | |
| SCHEMBL30797900 | 0.92 | MME (0.63) | MMEGNPATLTA4HNAALAD2GAA | |
| SCHEMBL135366 | 0.92 | MME (0.61) | MMENAALAD2 | |
| SCHEMBL11548564 | 0.92 | MME (0.61) | MMENAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |